Cresco acted as lead counsel in the formation of Azalea Vision and its subsequent €8M Series A Investment round. Lead investor Imec.xpand was joined by Elaia, Sensinnovat, and Shigeru in a strong international investor syndicate.
Azalea Vision is developing an innovative, IP-protected, medical device integrating an active light management system inside a contact lens. The product will significantly improve the quality of life of millions of patients by reducing their light sensitivity and increasing their visual acuity.
David Dessers and Olivier Van Raemdonck led the Cresco team that advised the stakeholders in this transaction.
More information on this transaction can be found in De Tijd.
For any further information or questions, please contact David Dessers or Olivier Van Raemdonck.